AZD0284

oral RORC2 inverse agonist for psoriasis

100 mg PO BID, Ph. I term. due to preclin. Data

from opt. of lit. inverse agonist

Journal of Medicinal Chemistry

AstraZeneca, Gothenburg, Sweden

The AstraZeneca oral RORgt inverse agonist, AZD0284, is an inverse agonist of the nuclear receptor RORC2 (RORγt). Reviewer Chris Gampe says, “targeting the activation and function of Th17 cells has been successful…


 become a member to continue reading

Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.

  • Stay up-to-date and save more time with exclusive members-only content
  • On-board new team members with educational content and case studies
  • Generate ideas and discussion with easy-to-read slide decks
  • Generate ideas and discussion with easy-to-read slide decks